Trial Search Results

Study to Intervene With Nutrition for Gastroparesis

The study is a self-controlled study in which we will assess the safety and efficacy of Kate Farm Peptide 1.5 tube feeding in patients with gastroparesis, relative to their pre-enrollment tube feeding regimen.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Dietary Supplement: Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula




Inclusion Criteria:

   - Male or female gender

   - Ages 18 to 65

   - Established diagnosis of gastroparesis confirmed by gastric emptying study within the
   last 2 years.

   - No changes to gastroparesis medications in the 3 months prior to recruitment.

   - Patients with hysterectomy, appendectomy, cholecystectomy and fundoplication are ok to

   - Jejunostomy tube placed greater than or equal to 1 year prior to recruitment.

   - Greater than or equal to 70% of daily caloric intake (DCI) from tube feeds.

   - Able to give informed consent.

   - Ability to adhere to the study visit schedule and other protocol requirements.

Exclusion Criteria:

   - Are nursing or pregnant.

   - Diagnosis of mechanical small bowel obstruction within 3 months prior to recruitment.

   - Patients with a history of gastric surgery, including gastrectomy, small bowel
   resection or bariatric surgery.

   - The use of narcotic medications in the month prior to study enrollment or during the
   study period.

   - Diagnosis of short gut syndrome.

   - Diagnosis of small intestinal bacterial overgrowth.

Ages Eligible for Study

18 Years - 65 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Elvi Sanjines